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Autoimmune Encephalomyelitis in Common 
Marmosets: A New Model for 
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Donald Canfield, DVM,? and Stephen L. Hauser, MD" 
A chronic relapsing-remitting form of experimental autoimmune encephalomyelitis was induced in the common 
marmoset Callithrix jacchus following a single immunization with human white matter. Individual animals in this 
species are born as natural bone marrow chimeras, allowing transfer of functional T-cell populations between geneti- 
cally distinct siblings. The acute disease was characterized clinically by mild neurological signs. Pathologically, the 
disease was characterized by perivascular mononuclear cell infiltrates, large foci of primary demyelination, and reactive 
astrogliosis. No animal displayed hemorrhagic-necrotic lesions or polymorphonuclear cell infiltrates characteristic of 
other acute forms of primate experimental autoimmune encephalomyelitis. A late spontaneous relapse occurred in 
each of 2 animals followed for 3 to 12 months subsequent to recovery from the acute attack. In these animals, chronic 
lesions consisted of mononuclear cell infiltrates within large sharply defined areas of demyelination and astrogliosis, 
and resembled active plaques of chronic multiple sclerosis. Proliferative responses to myelin basic protein but not to 
myelin proteolipid protein were present in peripheral blood lymphocytes of immunized animals. Furthermore, myelin 
basic protein-reactive T-cell lines derived from immunized donors induced clinical signs of experimental autoimmune 
encephalomyelitis when adoptively transferred into a sibling, indicating that myelin basic protein-reactive T cells 
can induce disease in this species. Because of its clinical and pathological similarity to human multiple sclerosis and 
the ability to adoptively transfer experimental autoimmune encephalomyelitis, this model system should prove useful 
in the analysis of the immunological mechanisms responsible for autoimmune demyelination in outbred primates. 
Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL. Active and passively 
induced experimental autoimmune encephalomyelitis in common marmosets: 
a new model for multiple sclerosis. Ann Neurol 1995;37.519-530 
Experimental autoimmune encephalomyelitis (EAE) 
describes a group of inflammatory diseases of the cen- 
tral nervous system (CNS) that are induced in suscepti- 
ble animals by immunization with myelin antigens or 
by adoptive transfer of sensitized T cells to syngeneic 
recipients [l-61. In inbred rodents, chronic and relaps- 
ing-remitting forms of EAE that have been described 
resemble human multiple sclerosis (MS) [7-91. More 
than any other disease model, EAE has contributed 
to current concepts of T-cell-mediated organ-specific 
autoimmunity. For example, the understanding of ge- 
netic determinants of susceptibility, environmental 
modifiers, the pathogenic T-cell repertoire, antigen/ 
epitope recognition, homing, mechanisms of suppres- 
sion, and cellular contributions of the target organ have 
been defined in models of EAE [10-151. EAE has also 
served in the testing of scores of therapies for MS, yet 
efficacy has often not been a predictor of benefit in 
humans. Phylogenetic differences between inbred ro- 
dents and outbred humans have probably limited the 
usefulness of EAE as an MS model. 
EAE has been described in macaques, yet acute CNS 
lesions in these species are hyperacute, hemorrhagic, 
and destructive, unlike those in MS [16-191. Chronic 
EAE can be induced in some macaques, most notably 
cynomolgus monkeys, in which the course is character- 
ized by relapses and remissions, by CNS inflammation, 
demyelination, and gliosis, and by T-cell responses to 
myelin basic protein (MBP) that correlate with the de- 
velopment of clinical signs C20, 2 11. EAE has also been 
From the "University of California, San Francisco, Department of 
Neurology, San Francisco, CA; ?The New England Regional Primate 
Received Jun 29, 1994, and in revised form Oct 13. Accepted for 
publication Nov 22, 1994. 
Research Center, Southborough, MA; and fHarvard Medical 
School, Beth Israel Hospital, Boston, MA. Address correspondence to Dr Hauser, Department of Neurology, Universitv of California. San Francisco. Box 01 14. San Francisco. 
CA 94143. 
Copyright 0 1995 by the American Neurological Association 5 19 
described in owl and squirrel monkeys C22-241. The 
outbred nature of nonhuman primates has limited their 
value as disease models, since adoptive transfer of ge- 
netically compatible T cells between animals is valuable 
for elucidating the role of specific T-cell populations 
in EAE. To date, n o  practical model  of an MS-like 
lesion has been described in  nonhuman primates. 
Here we describe the induction and the characteris- 
tics o f  EAE in the common marmoset Callithrix jac- 
chus. These  are small N e w  World monkeys (weighing 
in adulthood 300-400 gm), whose care and handling in  
captivity is relatively simple. Actively induced EAE 
in C. jacchus is characterized clinically by mild neuro- 
logical signs and a relapsing-remitting course, and 
pathologically by mononuclear cell infiltration, primary 
demyelination, and reactive gliosis. A further advan- 
tage for the  use of common marmosets as a model  for 
EAE is that they are born as naturally occurring bone 
marrow chimeras [25] .  While  individual animals from 
multiple births arise from separate ova that are fertil- 
ized independently, the placentae of the  developing 
animals fuse, resulting in  a cross circulation of bone 
marrow-derived elements between the developing fe- 
tuses. Thus,  while the  animals are genetically distinct, 
they share and are tolerant of each other's bone  mar- 
row-derived cell populations. We now demonstrate 
that it is possible to adoptively transfer EAE by T-cell 
transfer between members of a chimeric set of twins. 
Acute  and chronic EAE, created in a species whose 
immune and nervous system genes are phylogeneti- 
cally close to those of humans, represents a unique 
disease model  that should prove useful in  elucidating 
immune mechanisms of CNS demyelination. 
Mater ia l s  and M e t h o d s  
Animals 
C. jacchus animals were maintained in primate colonies at the 
University of California, San Francisco (UCSF) and the New 
England Regional Primate Research Center. The animals 
used in this study were cared for in accordance with the 
guidelines of the Committee on Animals of the Harvard 
Medical School and UCSF, and those of the Committee on 
Care and Use of Laboratory Animals of the Institute of Labo- 
ratory Animal Resources, National Research Council. A 
maximum of 2.5 ml of blood every other week was taken 
from each animal. 
Induction of Experimental Autoimmune 
Encephalomyelitis 
Nine animals were immunized with 200 mg of fresh-frozen 
postmortem human brain white matter homogenate (BH) 
emulsified with complete Freund's adjuvant (CFA) con- 
taining 3 mgiml of killed Mycobacterium tuberculosis (H37 Ra 
strain). Intradermal injections (total volume of 0.6 ml/animal) 
were divided in four sites on the dorsal axilla and inguinal 
region. On the day of immunization and again 2 days later, 
10" inactivated Bordetella pertussis organisms (Bordetella per- 
tussis vaccine, Massachusetts Public Health Department Bio- 
logical Laboratories, Boston, MA) were diluted in 10 ml of 
saline solution and administered by the intravenous route. In 
animals that developed fever due to the initial pertussis vac- 
cine, the second pertussis injection was delayed by 1 to 2 
days. Two to 5 weeks after immunization, some animals de- 
veloped local skin ulcerations related to the CFA. In these 
animals, cephalexin (20 mg/kg twice daily for 10 days) was 
administered intra'muscularly to prevent secondary infection. 
EAE was assessed by clinical and pathological criteria. A 
standardized scoring system was employed to record the se- 
verity of clinical disease: 0 = normal neurological findings; 
1 = lethargy, anorexia, weight loss; 2 = ataxia, and either 
paraparesis/monoparesis, sensory loss, or brainstem syn- 
drome including gaze palsy, or blindness; 3 = paraplegia or 
hemiplegia; 4 = quadriplegia. 
Animals were killed at different times after immunization. 
The CNS was removed and fixed in 10% formalin. Paraffin 
sections of brain and spinal cord were prepared and stained 
with hematoxylin and eosin, or with Lux01 fast blue. For each 
coronal brain section or horizontal spinal cord section, the 
histopathological findings of inflammation and demyelination 
were each independently graded according to an arbitrary 
scale: 
Inflammation Score 
0 N o  inflammation present 
+ Rare (1-3) perivascular cuffsiaverage whole section 
+ + Moderate numbers (3-10) of perivascular cuffslsec- 
tion; may have meningeal inflammation 
+ + + Widespread perivascular cuffing and parenchymal in- 
filtration by inflammatory cells 
Demyelination Score 
0 No demyelination present 
1 + Rare (1-3 lesions/section) foci of demyelination 
2 + Moderate (3- 10 lesionsisection) demyelination 
3 + Extensive demyelination with large confluent lesions 
Proliferation Studies 
Under sterile conditions, spleen and lymph node tissue was 
harvested and single cell suspensions prepared by passage 
through a stainless-steel mesh. Peripheral blood mononuclear 
cells (PBMCs) were prepared from heparinized venous blood 
within 3 hours of venipuncture by density gradient centrifu- 
gation using Ficoll-Hypaque. Spleen cells, lymph node cells, 
or PBMCs (2 x 105/well) were cultured in a total volume 
of 200 p1 in round-bottom microtiter plates (Falcon Plas- 
tics, Oxnard, CA) in culture medium consisting of RPMI 
1640 supplemented with 10% controlled processed serum 
replacement-2 (Sigma Pharmaceuticals, St. Louis, MO), 2 
mM L-glutamine (Gibco Laboratories, Grand Island, NY), 
20 mM 4-(2-hydroxyethyl)- 1-piperazine ethane-sulfonic acid 
(HEPES) buffer (Sigma), and penicillin-streptomycin 
(Gibco). To some wells the following antigens (final concen- 
tration) were added: 
A. Human MBP (50 pg/ml) prepared by the method of 
B. Human proteolipid protein (PLP) prepared from a human 
Deibler and colleagues 1261. 
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brain total lipid extract [27]; lipid was removed by chro- 
matography on a Sephadex LH 60 column eluted with 
chloroform :methanol: acetic acid {28f. The eluate was 
converted to the water-soluble form as described by Lees 
and Sakura 1291. 
C. Human BH, 0.l%%, sonicated and irradiated. 
After 4 days of incubation, r3H]thymidine (1 pCi/well) was 
added, cells were harvested 16 hours later, and thymidine 
incorporation was measured in a scintillation counter. Prolif- 
erative responses were expressed as stimulation indices (SIs), 
defined as the stimulated cultures (counts per minute) in un- 
stimulated cultures in triplicate wells. 
Adoptive Transfer Experiments 
SHORT-TERM LINES. Following onset of neurological signs 
of EAE, the animals were sacrificed and the spleen and drain- 
ing lymph nodes were aseptically removed. Washed lymph 
node (3 x 106/ml) and spleen (1O6//ml) cells were cultured 
together in the presence of human MBP (50 pg/ml) in com- 
plete medium (RPMI 1640 containing 10% controlled pro- 
cessed serum replacement-2) (Fig 1). After 4 days the re- 
sponding cell population was enriched by Ficoll-Hypaque 
density gradient centrifugation, washed, and resuspended in 
growth medium, that is, complete medium containing 55% 
human T-cell growth factor (TCGF) (Cellular Products), 40 
unitdm1 of human recombinant interleukin (1L)-2 (Ha- 
zelton), and 4 u n i d m l  of human recombinant IL-4 (Gen- 
zyme). After 12 days in growth medium, the cells were 
washed, restimulated with MBP for 3 days in the presence 
of equal numbers of syngeneic spleen cells (frozen prior to 
use) as antigen-presenting cells (APCs), cultured in growth 
medium for 1 additional day, and washed. Activated cells 
were again enriched by density gradient centrifugation and 
washed, and 40 x lo6 cells were resuspended in 5 ml of 
phosphate-buffered saline solution (PBS) and injected intra- 
venously into the naive (unimmunized) sibling (see Fig 1). 
Each transferred cell line was subsequently expanded in vitro 
by alternating cycles of stimulation with MBP and growth 
medium for epitope mapping studies. 
LONG-TERM LINES. Long-term MBP-reactive T-cell lines 
were derived by limiting dilution. Mixtures of splenic and 
lymph node cells (ratio of 2 : l )  were cultured at 10' cells/ 
well in 96 round-bottom well plates with purified human 
MBP (50 pgiml final concentration) in complete medium. 
After 3 days the culture medium was supplemented with 
growth medium and this medium was then changed every 3 
days for 9 days. T cells were restimulated at the end of the 
cycle by addition of 2 x lo5 freshly isolated chimeric 
PBMCs pulsed with MBP (50 &ml) and irradiated (30 Gy) 
as APCs. Lines were expanded by multiple cycles of restimu- 
lation with MBPiAPCs followed by culture in growth me- 
dium. 
At the end of the stimulation cycles, 10' T cells were 
rested for 48 hours in controlled processed serum replace- 
ment-2 medium, then restimulated with MBP (50 pg/ml) in 
the presence of an equal number of irradiated (30 Gy) freshly 
isolated PBMCs as APCs. Growth medium was added after 
48 hours, and 24 hours later cells were harvested, washed 
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bone marrow chimeric state. (B) Method for induction of adop- 
tive transfer of experimental autoimmune encephalomyelitis 
between chimeric siblings mediated by myelin basic protein 
(MBP)-reactive T-cell lines. WM = white matter; IL = in- 
terleukin; TCGF = T-cell growth factor; APC = antigen- 
presenting cell. 
with RPMI, resuspended in 2 ml of 0.9% saline solution, 
and injected intravenously into the recipient. 
All recipient animals received intravenous injections of 
10"' Bordetella pertussis on the day of transfer and again 48 
hours later. 
Lines were screened for fine antigen specificity using a 
panel of 20-mer overlapping peptides corresponding to the 
amino acid sequence of human MBP. Human and monkey 
MBP differ by only 4 of 172 amino acids (aa) [30}. Prolifera- 
tive responses (SIs) were measured as described above, using 
5 x lo4 T cells stimulated with lo5 irradiated (30 Gy) frozen 
autologous spleen cells or freshly isolated chimeric PBMCs, 
in the presence of 100 kg/ml of each MBP peptide. 
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Results 
Experimental Autoimmune Encephalomyelitis Induced 
by Active Immunization in  C. jacchus Monkeys 
Signs of EAE developed in all 9 animals immunized 
with white matter homogenate. The onset of the initial 
illness ranged from day 7 to day 30 following immuni- 
zation. Commonly present were signs of ascending 
paraparesis or paralysis, tremor, loss of pain sensation 
in the tail or hind legs, and blindness. The initial clinical 
deficit stabilized rapidly, within 24 hours from the on- 
set, at a median score of 2.0. No C. jaccbm had an 
initial score greater than 3 (Table). 
Three animals (Animals 96-89, 183-88, and 130-88) 
were not sacrificed at disease onset and were followed 
for 3, 6, and 18 months, respectively. In each animal, 
complete clinical recovery from the initial attack oc- 
curred between 1 and 4 months after immunization 
(Fig 2). Two animals were followed without additional 
intervention, and spontaneous relapses occurred in 
both. In the first, a relapse occurred on day 180 and 
persisted 4 months and remitted without residual defi- 
cits (Fig 2A). In the second, a spontaneous relapse on 
day 1 10 resulted in severe quadriplegia, necessitating 
euthanasia (Fig 2B). A third animal was actively reim- 
munized following recovery, and recurrent disease de- 
veloped 27 days later. This suggests that remission was 
not associated with resistance to reinduction (Fig 2C), 
in contrast to most rodent models of EAE [31, 32). 
Based on this single observation we could not exclude 
the possibility that a “spontaneous” relapse that was 
unrelated to the reimmunization occurred. 
Puthology 
In acute EAE, the spinal cord appeared macroscopi- 
cally soft and swollen. On microscopic examination, 
acute lesions were multiple, perivascular in location, 
and with rare exceptions, restricted to white matter. 
Occasional lesions were noted at gray-white matter 
junctions. Although lesions were present throughout 
the neuroaxis, spinal cord lesions were particularly 
prominent. Involvement of the cord was relatively 
symmetrical and predominated in posterior and lateral 
funiculi (Figs 3A-3D). Perivascular cellular infiltrates 
were comprised exclusively of mononuclear cells (Figs 
3E, 3F). Plasma cells were rare. In no lesions were 
polymorphonuclear cells, hemorrhage, or necrosis ob- 
served. The most remarkable feature of the acute le- 
sion was the large size and the sharply delimited areas 
of primary demyelination that were associated with cel- 
lular infiltrates. These areas were densely packed with 
infiltrating macrophages containing myelin debris, and 
were associated with early reactive gliosis. 
Animals 183-88, 96-89, and 130-88 were sacrificed, 
respectively, 3, 6, and 18 months after the onset of 
neurological signs. In each, inflammatory infiltrates 
were present, located not only in perivascular locations 
but also diffusely in white matter parenchyma corre- 
sponding to foci of demyelination and dense reactive 
gliosis (Fig 4). Lttle meningeal or subpial inflammation 
was present (see Figs 4A, 4B). Within infiltrates, most 
cells had the morphological appearance of monocytes 
or macrophages. Lymphocytes also were present in 
chronic lesions, located in a perivenular distribution or 
at the lesion edge. The characteristics of these round 
or oval, sharply demarcated chronic lesions (i.e., mono- 
nuclear cell infiltrates, demyelination, and gliosis cen- 
tered around a venule) were indistinguishable morpho- 
logically from plaques observed in human MS (see Figs 
4 E ,  4F). 
Lymphocyte Prolifrative Responses 
Proliferative responses to BH, MBP, and PLP were 
measured from PBMCs prior to immunization and 
from PBMCs, spleen cells, and lymph node cells at the 
Clinical and Histopathological Findings in Experimental Autoimmune Encephalomyelitis Induced in Callithrix jacchus Monkey1 
Pathology‘ 
Score (Day) 
Animal No.  Time of Onset“ Maximum Scoreb at Time of Deaths” Inflammation Demyelination 
130-88 30, 180 3, 2 0 (550) + +  + +  
13 1-88 23 3 3 (25) + +  + + +  
183-88a 24 2 (ND) ND ND 
183-88bd 155 3 3 (188) + +  + + +  
367-88 29 2 2 (33) + + +  + + +  
1 16-89 18 2 2 (25) + +  + + r  
344-89 14 2 2 (40 )  + +  + + e  
54-90 16 2 (ND) ND ND 
48-90 16 2 (ND) ND ND 
96-89 7, 110 2, 4 4 (114) + + +  + + +  
‘Days after immunization. 
bClinical scoring system described in Materials and Methods. 
‘See Materials and Methods for explanation of grading system. 
“Animal 183-88 was reimmunized at day 128 after first immunization. 
‘Spinal cord abnormalities were less severe in Animals 116-89 and 344-89 than in the other animals examined 
N D  = not done 
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Fig 2. The clinical course of experimental autoimmune encepha- 
lomyelitis in 3 representative animals. (A) Animal 130-88. 
(B)  Animal 96-89. (Ci Animal 183-88. 
time of death. From PBMCs, a proliferative response 
to both B H  and MBP was present in most animals (Fig 
5). Specific responses of spleen and lymph node cells 
to MBP and B H  were also present in most animals at 
the time of death. By contrast, proliferative responses 
to PLP could not be detected in most animals studied 
(see Fig 5). These data suggest that in acute EAE, re- 
sponses to myelin antigens that are detectable in pe- 
ripheral blood reflect to some degree those present 
in lymphoid tissue. Furthermore, they indicate that a 
specific T-cell response to MBP was present in affected 
animals. 
Adoptive Transfer Experimental Autoimmune 
Encephalomyelitis 
In total, four adoptive transfers were performed. In 
two transfers that employed short-term MBP-reactive 
T-cell lines, clinical signs of EAE developed in both 
recipients. In the first, acute paraparesis was followed 
by complete clinical recovery lasting more than 2 
months (Fig 6A). In the second, a relapsing-remitting 
disease followed adoptive transfer (Fig GB). 
Two other transfers employed long-term MBP- 
reactive T-cell lines. One line (17.i5.2.28, SI = 16, 
specificity aa 3 1-50) induced paraparesis and sensory 
loss in the recipient 8 days following transfer (Fig 6C). 
This animal partially recovered but then one additional 
spontaneous relapse developed during a 1-year period 
of additional observation. A second MBP-reactive line 
(21.C.2.100, SI = 21, specificity aa 92-111) failed to 
induce clinical disease when the recipient animal was 
observed for 120 days following adoptive transfer. 
Disease severity was milder in EAE mediated by 
adoptive transfer of T-cell lines (maximum score of 
2.0 in each recipient) than in EAE induced by active 
immunization with BH/CFA. Adoptive transfer recipi- 
ents were sacrificed 3 to 12 months following the initial 
induction of EAE. In each of these 3 recipients, post- 
mortem examination was performed. In 2 transfer re- 
cipients, no abnormalities of significance were found, 
and in the third only a single necrotic focus of uncer- 
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E F 
Fig  3. Pathological features of acute experimental autoimmune 
encephalomyelitis in C .  jacchus. (A-D) Horizontal thoracic spi- 
nal cord sections (Animal 13 1-88) illustrate perivascular in- 
jammation, macrophage infiltratron, and large demyelinated le- 
sions in the lateral and posterior funiculi. (A: Hematoxylin and 
eosin {HCE}, X 50 before 9% reduction: B: HCE, X 100 be- 
fore 3>% reduction.) (C) Large demyelinating lesion within the 
posterior columns: note the extensive demyelination with sharply 
defined edges and dense macrophage infiltration. (Luxol fast 
bluelperiodic acid-Schtff stain, x 160 before 36% reduction.) 
ID) In  the lateral columns, perivascular cufing and sur- 
rounding demyelination. ( x I 5 0  before 36%. reduction.) 
(E ,  F )  A section through the covona radiata at the level of the 
caudate putamen (Animal 367-88) illustrates a multifocal peri- 
vascular infiltrate and early astrogliosis. (E: X 200 before 36% 
reduction; F: x 500 before 36% reduction.) 
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E 
F i g  4. Pathological features of chronic experimental autoimmune 
encephalomyelitis in C. jacchus. (A) Thoracic spinal cord (Ani- 
mal 1 30-881. Confluent perivascular and subpial demyelination 
in the posterior funiculi. (Luxol fast bluelperiodic acid-Schiff 
stain. x 100 before 34% reduction.) (B) Dorsal pons adjacent 
to  the fourth ventricle. Multifocal perivenular infiltrates. (Hema- 
toxylin and eosin {HQE}, X 133 before 35% reduction.) 
(Ci Cerebellum (Animal 183-881. Large demyelinating lesion 
with densely packed macrophages and multiple perivascular in- 
F 
jammatory cufs.  (HGE, X 133 before 33% reduction.) (0) A 
higher-power view ofthe lesion edge. ( x 250 before 3>% reduc- 
tion.) (E) Animal 183-88. Lesion in corona radiata comprised 
of perivascular mononuclear cell inflammation and foamy macro- 
phages; reactive astrocytes and demyelination (pale perivascular 
zone) can be identzj5ed. (H6E,  x 400 before 35% reduction.) 
( F )  Animal 130-88. External capsule. Perivenous infEamma- 
tion, denyelination, and astrogliosis. (Luxol fast bluelperiodic 
acid-Schiff stain, x 200 before 36% reduction.) 
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Fig  5 .  T-lymphocyte reactivity to brain antigens during the 
course of experimental autoimmune enrephalomyelitis (EAE). 
Data are expressed aJ- stimulation indices (Sls) to MBP, BH, 
and PLP. For peripheral blood mononuclear cells ( PBMCs), SIs 
are J hown at baseline before immunization and again following 
development of clinical signs of EAE. For spleen and lymph node 
relh. preimmunization Sls were not obtained. In PBMCs, 
spleen, and lymph nodes, all EAE time point studies were per- 
formed from cells harueA-ted at the time qf death corresponding t o  
the following number of days afer the initiuf upprarance of rlin- 
ical signs: Animal 1.3 1-88 = 3 days; Animal 183-88a = 5 
days; Animal 183-886 = 5 days; Animal 11 6-89 = 7 days; 
Animal 344-89 = 26 days; Animal 54-90 = 2 days; and 
Animal 48-90 = 2 days. MBP = myelin basic protein; 
BH = brain white matter hornogenate; PLP = proteolipid pro- 
tein. 
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F i g  6. Clinical course characteristics of adoptive transfer experi- 
mental autoimmune encephalomyelitis (EAE) mediated by myelin 
basic protein (MBP)-reactive T cells in C. jacchus. (A-C) 
Three independent transfers are summarized. Donor animals 
(left) were actively immunized, and at the onset of EAE spleen 
and lymph node cells were harvested. Following expansion, each 
T-cell line (A, B,  or C )  was adoptively transferred into a differ- 
ent chimeric recipient (right). Stimulation indices (SI) of whole 
splenic and lymph node celh at the time of death, and of each 
transferred line at transfer, are noted. 
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tain significance was identified. The paucity of post- 
mortem changes were in marked contrast to the wide- 
spread abnormalities present in the active immuni- 
zation EAE group. 
Following expansion in vitro, each of the three lines 
capable of mediating EAE by adoptive transfer recog- 
nized a different region of the MBP molecule-aa 11 
to 30, 31 to 50, and 153 to 172, respectively. These 
data suggest that the repertoire of MBP-reactive T cells 
in C. jaccbus may be diverse, and that multiple epitopes 
may be capable of stimulating an encephalitogenic re- 
sponse in this species. 
Discussion 
In this report we describe a nonhuman primate model 
of EAE that is characterized clinically by mild neuro- 
logical signs and a chronic course, and pathologically 
by primary CNS demyelination. In the past, EAE has 
been extensively studied in primates, theoretically an 
ideal model system for MS because of the genetic simi- 
larities between human and nonhuman primates. How- 
ever, in these animals a chronic relapsing course is not 
reliably observed {20, 2 11 and the hyperacute necrotic- 
hemorrhagic CNS lesions that are characteristic of 
acute EAE differ substantially from the typical pathol- 
ogy of human demyelinating diseases. 
In earlier experiments that employed different im- 
munization regimens, C. jaccbus was found to be resis- 
tant to actively induced EAE (data not shown). Intrave- 
nous administration of Bordetella pertus.ris vaccine in 
combination with white matter in adjuvant was re- 
quired for active induction of disease. This require- 
ment for pertussis vaccine distinguishes EAE in C. jac- 
cbus from other nonhuman primate forms of EAE, 
although in other species, for example, the H-2’ 
mouse, a similar immunization strategy is required [3].  
In C. jaccbus, Bordetellu pertussis may function as an 
adjuvant or as a modifier of blood-brain barrier integ- 
rity [33, 341; it does not by itself induce disease [35]. 
Clinical features of EAE in C. jaccbus, notably a chronic 
relapsing-remitting course, mild neurological signs 
(mean clinical score of 2), and complete recovery from 
the initial attack, distinguish it from other primate 
models of EAE. In macaques, clinical scores of 4 or 
higher are common during the initial attack and are 
associated with fatal outcome [20, 2 11. Furthermore, 
induction of chronic relapsing EAE in macaques has 
been difficult. In rhesus macaques, induction of chronic 
disease generally requires steroid or other treatment 
administered at the time of acute disease, interventions 
that limit the usefulness of this model [20). In cyno- 
molgus monkeys, a chronic course may occur without 
administration of immunosuppressive drugs, yet ap- 
proximately half of immunized animals die from the 
acute disease [21). 
Acute EAE lesions in C. jaccbus were characterized 
by scattered perivascular inflammatory infiltrates sur- 
rounded by large concentric areas of demyelination 
and associated with intense macrophage infiltration and 
mild astrogliosis. Inflammation was largely restricted to 
white matter in brain and spinal cord. The prominent 
demyelination, and the relatively sparse mononuclear 
cell infiltration, are the major distinguishing features 
of acute EAE in C. jacchus. By contrast, inflammation, 
rather than demyelination, is the predominant feature 
of acute EAE in rodents. In the Lewis rat, for example, 
lesions predominate in the spinal cord and involve gray 
as well as white matter, and no demyelination is pres- 
ent {lo]. Similarly, in the guinea pig and mouse, lim- 
ited or scant demyelination occurs in acute EAE El-7, 
91. In larger species, for example, rabbits and macaque 
monkeys, demyelination is observed in acute EAE but 
hemorrhagic and necrotic lesions and polymorphonu- 
clear cell infiltration also occur [19-21}. 
Compared with acute lesions, chronic lesions con- 
tained denser and more widely scattered mononuclear 
cell infiltration, and more prominent gliosis. This was 
particularly evident in the spinal cord. Chronic forms 
of EAE have been previously described in rats [S], 
mice [7 ,  91, guinea pigs [4},  and macaques [2O, 213, 
models that are in general associated with more promi- 
nent demyelination than is present in acute EAE. In 
C. jacchus, the sharply demarcated areas of demyelin- 
ation and gliosis concentric to the perivascular infil- 
trates indicate the formation of plaques, a feature con- 
sistently present in this model. 
The natural bone marrow chimerism of C. jacchus 
permitted the adoptive transfer of neurological signs 
of EAE by MBP-reactive T-cell lines. Transfer was suc- 
cessful with two MBP-reactive short-term lines, and 
with one of two MBP-reactive long-term lines. The 
failure of one long-term line to transfer EAE was not 
due to a difference in its reactivity to MBP measured 
by its SI. The nonencephalitogenic long-term line rec- 
ognized aa 92 to 11 1 of MBP, a fragment not recog- 
nized by any encephalitogenic line in this study. It is 
possible that the nonencephalitogenicity is due to rec- 
ognition of this particular region of MBP. However, 
in rodent EAE models, it has been observed that some 
MBP-reactive clones recognize encephalitogenic frag- 
ments of MBP but fail to transfer EAE because of their 
pattern of cytokine secretion [36]. In C. jaccbw, we 
found that most MBP-reactive T-cell clones derived 
from peripheral blood do induce EAE by adoptive 
transfer [35].  Current work will define whether T-cell 
phenotypes defined by their cytokine profiles are pre- 
dictive of encephalitogenicity in marmosets. 
Adoptive transfer of MBP-reactive T-cell lines re- 
sulted in clinical signs of EAE, but no demyelination 
was evident at autopsy. We also found that active im- 
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munization with purified MBP induces inflammatory 
changes in the meninges and peripheral nerve roots, 
but little or no demyelination (C. Genain, unpublished 
data, 1995). This lack of demyelination contrasts 
sharply with the large demyelinating lesions that follow 
immunization with whole white matter. In addition 
to MBP, other myelin proteins may also be encephali- 
togenic in C. juccbus, as is the case for rodents. These 
include PLP [ 3 7) and myelin oligodendrocyte glyco- 
protein [38], which may induce demyelinating forms 
of EAE. Although in this report proliferative responses 
to PLP could not be detected, it is likely that a complex 
immune response to more than one white matter anti- 
gen underlies the primary demyelinating pathology in 
C. jaccbus CNS. This response may involve not only 
T cells but antibody production by B cells as well [39). 
Mapping data from three different encephalitogenic 
lines suggested that T-cell recognition of diverse epi- 
topes of MBP could result in clinical disease, although 
the possibility that a common, undetected epitope was 
recognized by all lines could not be excluded. Addi- 
tional data, however, employing MBP-reactive T-cell 
clones obtained from the circulation established con- 
clusively that the T-cell repertoire to MBP is diverse 
in C. jaccbus [ 3 5 ] ,  as also appears to be the case in 
humans [40). 
In summary, the data presented here indicate that a 
demyelinating form of acute EAE can be consistently 
induced in the primate species C. jucchus. To our 
knowledge, there exist no comparable examples of 
acute EAE lesions that mimic those of acute MS. 
Chronic lesions indistinguishable from lesions of 
chronic active MS are also described. A final advantage 
of the C. juccbus model is the natural bone marrow 
chimerism that exists between siblings and that makes 
possible the adoptive transfer of EAE by MBP-reactive 
T-cell lines. This should permit dissection of the immu- 
nological mechanisms that mediate autoimmune demy- 
elination in primates. 
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